The short version
4 companies supply this market — a reasonable cushion if one runs into trouble. The brand price has held steady around $461.44 per mL over the past year. Generic versions run $15.25 per mL — 30× cheaper. Historically, drugs in this position went on to a new shortage within 90 days about 0.6% of the time — roughly 4× the typical drug (0.1%).